AUS
NZ
UK
CA
USA
IND
Variscan Mines Limited (ASX:VAR), an Australian minerals exploration company, has officially issued 416,666,666 unquoted options to its Lead Managers under a mandate agreement linked to a placement announced in May 2026. These options, with an exercise price of $0.008 and expiring on 29 September 2028, were granted on 15 July 2026 and will not be traded on the ASX. The company filed an Appendix 3G with the ASX on 16 July 2026 confirming the completion of this securities issue and that no further securities remain outstanding under the transaction. Investors will be monitoring the total unquoted securities and potential exercise activity as Variscan advances its exploration efforts.
Key Points
- Variscan Mines Limited (ASX:VAR) is a minerals exploration company listed on the Australian Securities Exchange.
- The company has issued 416,666,666 unquoted options (ASX code: VARAH) to Lead Managers as part of a mandate agreement related to a May 2026 placement.
- These options carry an exercise price of $0.008 each and expire on 29 September 2028; they were issued on 15 July 2026 and are not ASX-quoted.
- Post-issuance, total unquoted VARAH options stand at 773,670,039, with 1,421,996,092 quoted ordinary fully paid shares outstanding.
- Investors should monitor potential option exercises, which could impact Variscan’s capital structure and shareholder dilution through to September 2028.
Variscan Mines Confirms Completion of 416.7 Million VARAH Options Issuance Dated 15 July 2026
On 16 July 2026, Variscan Mines Limited lodged an Appendix 3G with the ASX confirming the issuance of 416,666,666 unquoted options under the security code VARAH. These options were issued on 15 July 2026 and will not be listed or traded on the ASX. This issuance relates to a placement transaction initially disclosed on 11 May 2026 via an Appendix 3B, where the company announced a proposed securities issue. The Appendix 3G filing formally confirms the completion of that transaction with no further securities pending.
The company clarified that the VARAH options were issued to Lead Managers as part of their remuneration under the mandate agreement, rather than for cash consideration. This practice is common in junior exploration markets, where brokers or lead managers receive options to align their interests with the company’s equity performance. The filing confirms no additional securities remain to be issued under the May 2026 placement agreement.
VARAH Option Details: $0.008 Exercise Price and 29 September 2028 Expiry
Each of the 416,666,666 options carries an exercise price of $0.008 and expires on 29 September 2028, providing Lead Managers over two years to exercise if Variscan’s ordinary shares trade above this price. These disclosures comply with ASX Listing Rules, ensuring transparency on potential dilution. The options do not dilute shareholders unless exercised, which requires the share price to exceed $0.008 and for holders to elect to convert. Until exercised, these options remain unquoted and do not affect the ordinary share count. However, the significant volume of options outstanding means potential dilution is a material factor for investors to consider.
Background: May 2026 Placement Mandate Resulted in Lead Manager Option Issuance
The origin of this option issuance dates to 11 May 2026, when Variscan filed an Appendix 3B announcing a placement. Under the mandate agreement for that placement, Lead Managers were entitled to receive options as part of their fees. This equity-linked remuneration structure is typical in Australian small-cap markets, allowing companies to conserve cash while compensating advisers. The 16 July 2026 Appendix 3G confirms the fulfillment of this commitment and clarifies that no further securities remain outstanding from the May placement.
Variscan Mines' Capital Structure After VARAH Option Issuance
Following this issuance, Variscan’s capital structure includes 1,421,996,092 quoted ordinary fully paid shares (ASX:VAR). On the unquoted side, the company now has 773,670,039 VARAH options expiring 29 September 2028 at $0.008 exercise price. Additionally, 152,666,746 VARAW options expiring 30 November 2026 at $0.015 exercise price and 42,619,048 VARAX options expiring 30 November 2026 at $0.010 exercise price remain outstanding. Collectively, these unquoted options represent a significant potential increase in share count if exercised, with layered expiry dates and exercise prices that investors should monitor closely.
Near-Term Capital Considerations: VARAW and VARAX Options Expiring November 2026
The VARAW and VARAX option series, expiring 30 November 2026, present near-term capital events. VARAW includes 152,666,746 options at $0.015 exercise price, and VARAX includes 42,619,048 options at $0.010. Should Variscan’s share price exceed these levels before expiry, option holders may exercise, generating cash proceeds for Variscan but increasing share dilution. If prices remain below these thresholds, these options will expire worthless. The company provided no guidance on share price expectations or exploration funding related to these options.
Variscan Mines Overview and Context of Capital Raising
Variscan Mines Limited is a junior minerals exploration company focused on acquiring and exploring mineral assets in Australia. As is typical for junior explorers, Variscan relies on capital market transactions such as placements and option issuances to fund exploration, as it does not generate operating revenue during this phase. The May 2026 placement and related Lead Manager options issuance reflect this capital-raising cycle common in the junior exploration sector, balancing cash conservation with shareholder dilution management.
Impact of Growing Unquoted Options Pool on Existing Shareholders
The combined total of unquoted options across VARAH, VARAW, and VARAX series now stands at 968,955,833, relative to 1,421,996,092 quoted shares. While these options do not dilute shareholders until exercised, their potential exercise represents a material dilution risk. The largest series, VARAH, with an exercise price of $0.008, will be exercisable through to September 2028, depending on share price performance. Shareholders should consider this when evaluating Variscan’s capital structure and dilution exposure.
Non-Cash Nature of VARAH Option Issuance and Implications for Cash Position
Variscan confirmed that the 416,666,666 VARAH options were issued to Lead Managers as non-cash remuneration under the mandate agreement, meaning no immediate cash inflow resulted from this issuance. This approach conserves cash for the company but creates future dilution potential if options are exercised. The company did not disclose current cash balances or expenditure plans in this update; investors should refer to recent quarterly reports for detailed financial information.
Upcoming Milestones and Investor Considerations
With the VARAH option issuance finalized, investors should focus on Variscan’s ongoing exploration progress and any material project updates, which will be communicated separately under ASX disclosure rules. Capital structure developments to watch include the 30 November 2026 expiry of VARAW and VARAX options and their potential exercise outcomes. The longer-dated VARAH options expiring in September 2028 will also influence Variscan’s equity structure over the medium term. This update serves as an administrative confirmation rather than a commercial development, with no new strategic guidance provided.
